The Liability Threshold Model for Predicting the Risk of Cardiovascular Disease in Patients with Type 2 Diabetes: A Multi-Cohort Study of Korean Adults

Overview

Journal Metabolites

Publisher MDPI

Date 2020 Dec 30

PMID 33374401

Citations 2

Authors

Eun Pyo Hong

Seong Gu Heo

Ji Wan Park

Affiliations

Soon will be listed here.

Abstract

Personalized risk prediction for diabetic cardiovascular disease (DCVD) is at the core of precision medicine in type 2 diabetes (T2D). We first identified three marker sets consisting of 15, 47, and 231 tagging single nucleotide polymorphisms (tSNPs) associated with DCVD using a linear mixed model in 2378 T2D patients obtained from four population-based Korean cohorts. Using the genetic variants with even modest effects on phenotypic variance, we observed improved risk stratification accuracy beyond traditional risk factors (AUC, 0.63 to 0.97). With a cutoff point of 0.21, the discrete genetic liability threshold model consisting of 231 SNPs (GLT) correctly classified 87.7% of 2378 T2D patients as high or low risk of DCVD. For the same set of SNP markers, the GLT and polygenic risk score (PRS) models showed similar predictive performance, and we observed consistency between the GLT and PRS models in that the model based on a larger number of SNP markers showed much-improved predictability. In silico gene expression analysis, additional information was provided on the functional role of the genes identified in this study. In particular, , , , and appear to be major hubs in the functional gene network for DCVD. The proposed risk prediction approach based on the liability threshold model may help identify T2D patients at high CVD risk in East Asian populations with further external validations.

Citing Articles

Genetic modifiers of rare variants in monogenic developmental disorder loci.

Kingdom R, Beaumont R, Wood A, Weedon M, Wright C Nat Genet. 2024; 56(5):861-868.

PMID: 38637616 PMC: 11096126. DOI: 10.1038/s41588-024-01710-0.

Genomic risk prediction of cardiovascular diseases among type 2 diabetes patients in the UK Biobank.

Ye Y, Hu J, Pang F, Cui C, Zhao H Front Bioinform. 2024; 3:1320748.

PMID: 38239805 PMC: 10794561. DOI: 10.3389/fbinf.2023.1320748.

References

Flannick J . The Contribution of Low-Frequency and Rare Coding Variation to Susceptibility to Type 2 Diabetes. Curr Diab Rep. 2019; 19(5):25. PMC: 6451938. DOI: 10.1007/s11892-019-1142-5. View

Huang D, Sherman B, Lempicki R . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57. DOI: 10.1038/nprot.2008.211. View

Petrie J, Guzik T, Touyz R . Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Can J Cardiol. 2018; 34(5):575-584. PMC: 5953551. DOI: 10.1016/j.cjca.2017.12.005. View

Flannick J, Florez J . Type 2 diabetes: genetic data sharing to advance complex disease research. Nat Rev Genet. 2016; 17(9):535-49. DOI: 10.1038/nrg.2016.56. View

Yang J, Zaitlen N, Goddard M, Visscher P, Price A . Advantages and pitfalls in the application of mixed-model association methods. Nat Genet. 2014; 46(2):100-6. PMC: 3989144. DOI: 10.1038/ng.2876. View

Divers J, Palmer N, Langefeld C, Brown W, Lu L, Hicks P . Genome-wide association study of coronary artery calcified atherosclerotic plaque in African Americans with type 2 diabetes. BMC Genet. 2017; 18(1):105. PMC: 5723099. DOI: 10.1186/s12863-017-0572-9. View

Rosengren A, Smyth A, Rangarajan S, Ramasundarahettige C, Bangdiwala S, Alhabib K . Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study. Lancet Glob Health. 2019; 7(6):e748-e760. DOI: 10.1016/S2214-109X(19)30045-2. View

Wen W, Kato N, Hwang J, Guo X, Tabara Y, Li H . Genome-wide association studies in East Asians identify new loci for waist-hip ratio and waist circumference. Sci Rep. 2016; 6:17958. PMC: 4726286. DOI: 10.1038/srep17958. View

Qi L, Qi Q, Prudente S, Mendonca C, Andreozzi F, Di Pietro N . Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes. JAMA. 2013; 310(8):821-8. PMC: 3858847. DOI: 10.1001/jama.2013.276305. View

10.

Barrett J, Fry B, Maller J, Daly M . Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2004; 21(2):263-5. DOI: 10.1093/bioinformatics/bth457. View

11.

Gheith O, Farouk N, Nampoory N, Halim M, Al-Otaibi T . Diabetic kidney disease: world wide difference of prevalence and risk factors. J Nephropharmacol. 2017; 5(1):49-56. PMC: 5297507. View

12.

Duncan L, Shen H, Gelaye B, Meijsen J, Ressler K, Feldman M . Analysis of polygenic risk score usage and performance in diverse human populations. Nat Commun. 2019; 10(1):3328. PMC: 6658471. DOI: 10.1038/s41467-019-11112-0. View

13.

So H, Kwan J, Cherny S, Sham P . Risk prediction of complex diseases from family history and known susceptibility loci, with applications for cancer screening. Am J Hum Genet. 2011; 88(5):548-65. PMC: 3146722. DOI: 10.1016/j.ajhg.2011.04.001. View

14.

Kim B, Won J, Lee J, Kim H, Park J, Ha K . Diabetes Fact Sheets in Korea, 2018: An Appraisal of Current Status. Diabetes Metab J. 2019; 43(4):487-494. PMC: 6712228. DOI: 10.4093/dmj.2019.0067. View

15.

Kim Y, Go M, Hu C, Bum Hong C, Kim Y, Lee J . Large-scale genome-wide association studies in East Asians identify new genetic loci influencing metabolic traits. Nat Genet. 2011; 43(10):990-5. DOI: 10.1038/ng.939. View

16.

Lee S, Wray N, Goddard M, Visscher P . Estimating missing heritability for disease from genome-wide association studies. Am J Hum Genet. 2011; 88(3):294-305. PMC: 3059431. DOI: 10.1016/j.ajhg.2011.02.002. View

17.

Chatterjee N, Shi J, Garcia-Closas M . Developing and evaluating polygenic risk prediction models for stratified disease prevention. Nat Rev Genet. 2016; 17(7):392-406. PMC: 6021129. DOI: 10.1038/nrg.2016.27. View

18.

So H, Sham P . Exploring the predictive power of polygenic scores derived from genome-wide association studies: a study of 10 complex traits. Bioinformatics. 2017; 33(6):886-892. DOI: 10.1093/bioinformatics/btw745. View

19.

Parsa A, Chang Y, Kelly R, Corretti M, Ryan K, Robinson S . Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality. Clin Transl Sci. 2011; 4(1):17-23. PMC: 4373555. DOI: 10.1111/j.1752-8062.2010.00251.x. View

20.

Qi L, Parast L, Cai T, Powers C, Gervino E, Hauser T . Genetic susceptibility to coronary heart disease in type 2 diabetes: 3 independent studies. J Am Coll Cardiol. 2011; 58(25):2675-82. PMC: 3240896. DOI: 10.1016/j.jacc.2011.08.054. View